Becton, Dickinson and Company (BDX)

237,54 -0,71 (-0,30 %) À la clôture : 03:59PM EST

Becton, Dickinson and Company

1 Becton Drive
Franklin Lakes, NJ 07417-1880
United States
201 847 6800
https://www.bd.com

Secteur(s): Healthcare
Secteur d’activité: Medical Instruments & Supplies
Employés à temps plein: 73 000

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Thomas E. Polen Jr.	President, CEO & Chairman	3,93M	1,89M	1973
Mr. Christopher J. DelOrefice	Executive VP & CFO	1,99M	S.O.	1971
Ms. Shana Carol Neal	Executive VP & Chief People Officer	1,44M	S.O.	1965
Mr. David B. Hickey	Executive VP & President of Life Sciences Segment	1,41M	S.O.	1963
Mr. Thomas J. Spoerel	Senior VP, Controller & Chief Accounting Officer	S.O.	S.O.	1978
Ms. Elizabeth McCombs	Executive VP & Chief Technology Officer	S.O.	S.O.	1976
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.	Senior VP, Chief Scientific Officer & Co-Chair of Scientific Advisory Board	S.O.	S.O.	S.O.
Ms. Denise Russell Fleming	Executive VP of Technology & Global Services and Chief Information Officer	S.O.	S.O.	1970
Mr. Greg Rodetis	Head of Investor Relations	S.O.	S.O.	S.O.
Ms. Michelle Quinn	Executive VP & General Counsel	S.O.	S.O.	1969

Les montants ont été établis en date du 31 décembre 2022 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Becton, Dickinson and Company en date du 1 décembre 2023 est 10. Les scores principaux sont Audit : 9; Société : 9; Droits des actionnaires : 10; Compensation : 10.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.